Stop us if you’ve heard this before: You spend weeks onboarding a creative agency, only to receive a first draft that ignores basic industry guidelines. Suddenly, you’re spending your weekend translating legal feedback to a partner who doesn’t speak the language of pharma.
In the pharmaceutical world, this is the “fragmentation tax”, the cost of a partner who doesn’t prioritize compliance from day one, and it signals more than just a logistical headache – it means a compliance liability and a waste of high-value data.
When a single oversight can halt a global campaign, brands can no longer afford to bridge the gap between creative teams and legal consultants themselves.
This has led to an increased demand for full-service agencies that not only produce content, manage media buying and analysis and forward-looking recommendations, but can also navigate an increasingly rigid and unforgiving regulatory landscape.
But how do you separate the experts from the claimants?
At N365, we take the guesswork out of pharma marketing by embedding regulatory mastery into every level of our team. The latest milestone in this commitment is Account Executive Sara Ohlsén’s completion of the Information and Marketing (IMA) course at the Swedish Academy of Pharmaceutical Sciences.
Developed in collaboration with Lif, this credential focuses on the ethical guidelines and best practices that define pharmaceutical communication.
With a focus on the Ethical Rules for the Pharmaceutical Industry (LER), which define what is permissible, and oversight bodies like the Information Examiner Committee (IGN) and the Board for Assessment of Pharmaceutical Information (NBL), which actively review and rule on real-world marketing activity, our team operates with a clear understanding of how these standards are applied in practice.
For our partners in Sweden, this translates directly to:
– Faster Approvals: Creative built to withstand regulatory review and scrutiny from day one.
-Strategic Agility: The ability to shift budgets and audiences without legal friction.
-Seamless Execution: Balancing impact with adherence from concept to click.
While N365 has extensive experience with providing up-to-the-minute strategic advisory and data-driven distribution across the OTC, RX, and medical device industries, we recognize that in pharma, learning never stops, which is why these educational initiatives ensure that our strategic advisory and digital execution are always aligned with the highest industry standards.
In a high-stakes market, complacency is a liability. To drive real impact, you need a partner with the digital agility to reach modern audiences and the deep industry knowledge to navigate the regulatory maze safely.
If you’re ready to eliminate the fragmentation tax, contact us to schedule a meeting and see how we can help you grow your business.
